Individuals with high IgE at baseline in several diseases show clinical benefit with anti‐IL‐4Rα (dupilumab) treatment, for example, in alopecia areata, allergic asthma, and atopic dermatitis.163, 164, 165, 166. The gene discussed is IGHE; the disease is atopic eczema.